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INTRODUCTION
Gastric ulcer is a common health problem that affect a lot of population allover the world. Gastric ulcers are known as erosions of the gastric mucosa that may penetrate the muscle layer and perforate the stomach wall (1) . Ulcers are induced by predominance of aggressive factors to defensive factors, as the balance between both factors is necessary for maintaining intact and healthy gastric mucosa (2) .
Regulation of gastric mucosal blood flow is very important to maintain normal circulation and prevent occurrence of peptic ulcer. Prostaglandins and nitric oxide have been recognized as important factors for the regulation of gastric mucosal microcirculation, repair, and integrity (3, 4) . Inhibition of NO synthesis has been shown to produce acute gastric mucosal damge, whereas enhancement of NO synthesis exerts gastroprotective effects (5) . Ischemia of gastric mucosa is accompanied by enhanced generation of oxygenderived free radicals (ODFR) that may initiate a chain of reactions in membrane-bound lipids causing lipid peroxidation and cellular injury (6) . The most common lipid peroxide product is malondialdehyde (MDA), which is well known to cause cross-linking and polymerization of membrane components. Being diffusible, it also reacts with nitrogenous bases of DNA leading to more complicated sequelae (7) . The mucosal content of MDA (known alternatively as thiobarbituric acid reactive species, TBARS) was observed to increase with the development of gastric ulcers (8, 9) . Gastric ulcers associated with the use of nonsteroidal anti-inflammatory drugs (NSAIDs) remain a major clinical problem (10) . The continuous generation of prostaglandins by cyclooxygenase isoenzymes in the gastric mucosa helps to maintain an adequate mucosal blood flow and, also, stimulates the generation of mucus (11) . NSAIDs inhibit cyclooxygenase and thereby reduce the intrinsic ability of the mucosa to resist injury induced by endogenous and exogenous aggressors. Indomethacin, one of NSAIDs family, causes gastric ulcers through various processes, including generation of reactive oxygen species, initiation of lipid peroxidation, infiltration of leucocytes, induction of apoptosis, and inhibition of prostaglandin synthesis (12) . Decreased prostaglandin level impairs almost all aspects of gastroprotection and increases acid secretions which in turn, aggravate the ulcer (13) . (16) . Other investigators have suggested that protective effects of statins are mediated by enhancement of NO production, which is implicated in regulation of gastric acid secretion and modulation of gastric mucosal integrity together with endogenous prostaglandins (17) . Birnbaum and his co-workers (18) reported that oral pretreatment with atorvastatin caused an increase in NO and PGE 2 concentrations in the heart. Therefore, the present study aimed to elucidate the possible gastroprotective effects of atorvastatin on gastric ulcer induced by indomethacin and the possible putative mechanisms underlying these effects.
MATERIALS & METHODS

1-Animals:
Adult male albino rats weighing 150-200 g were used (from animal house of National Research Center, Cairo).
All experiments were performed during the same time of the day to avoid variations due to diurnal rhythm of putative regulators of gastric function. Rats were fasted for 24 hours with free access to water in mesh bottomed cages to minimize coprophagia (19) .
Experimental design:
Animals were randomly assigned to three experimental groups of eight animals included in each group: a-Control group; in which animals received distilled water for 7 days before being subjected to pyloric ligation. b-Indomethacin group (INDO); in which animals received distilled water for 7 days and then gastric ulceration was induced by a single intraperitoneal injection of indomethacin (Nile Co, Egypt) dissolved in sterile water in a dose 40mg/kg (20) . c-Atorvastatin(Ator)+INDO group; in which rats received 10 mg/kg of atorvastatin orally for 7 succesive days and there was another final dose one hour before indomethacin administeration (21) .
3-Pyloric ligation:
In order to collect gastric juice, pyloric ligation was, carried out in each animal 2 hours after indomethacin administration (22) . Under light ether anesthesia, a midline abdominal incision was performed; the pyloric portion of the stomach was gently mobilized and carefully ligated with a silk ligature around the pyloric sphincter taking care not to interfere with gastric blood supply. The abdominal incision was sutured and the animals were allowed to recover from anesthesia.
Assessment of gastric mucosal lesions:
Three hours after pyloric ligation, administration rats were killed with ether overdose. Their stomachs were removed, opened along the greater curvature and the gastric content of each stomach was collected. The stomachs were washed with ice cold saline and scored for gross mucosal lesion. Gastric mucosal lesions were examined using a magnifier and were expressed in the form of ulcer index (U.I.) and the severity factor, were determined according to the method of Peskar et al. 2002 (23) . The severity factor was measured by the gross lesion size. It was considered 0 if no lesions, 1 when lesion size is smaller than 1 mm, 2 when lesion size is 2-4 mm or 3 if the lesion exceeds 4 mm. The lesion score for each rat was calculated as the number of lesions multiplied by their respective severity factor .The mean lesion score for each group is the U.I of the group.
5-Collection and analysis of gastric juice:
The collected gastric juice after opening the stomach was centrifuged at 3000 rpm for 30 minutes to remove any solid debris and the volume of the supernatant was measured. Then, the supernatant was used for the analysis of pH, free and total acid-outputs, pepsin and mucin concentrations.
5.a. Determination of Acidity of the Gastric Juice:
The free acidity was determined by titration of a given volume of the gastric juice against 0.1N sodium hydroxide up to 5.5 as guided by a pH meter. The total acidity which is composed of both mineral and organic combined acids in the gastric juice was determined by completing the titration in the above procedure for determining free acidity to pH 7 as guided by the pH meter (24) .
5.b.The Colorimetric Assay for Mucins and Glycoproteins in the Gastric Juice:
It is a sensitive and specific method for saccharides, which are linked via N-acetylgalactosamine through O-glycosidic linkage to serine/threonine in mucins, the method is not affected by the carbohydrates present in other types of glycoproteins (25) .
c.Determination of the Proteolytic Activity:
This was determined by a modified spectrophotometric method (26) . The pepsin activity is the major factor involved in the proteolytic activity of gastric secretion. This activity can be determined in terms of the amount of proteases produced after incubation of the substrate for ½ hour with standard pepsin of the juice.
Biochemical analysis of gastric mucosa:
6.a.Determination of Lipid Peroxides:
The total amount of lipid peroxides in the gastric mucosa, was assayed using kits for the colorimetric determination of thiobarbituric acid (Biodiagnostic, Egypt) method. This measures the malondialdehyde equivalent substances, which are the breakdown products of lipid peroxides (27) .
6.b.Determination of Nitric Oxide in the Gastric Mucosa:
Gastric mucosal nitric oxide was determined using kits for the colorimetric determination of total nitrite (Biodiagnostic, Egypt). That assay determines the total nitric oxide based on the enzymatic conversion of nitrate to nitrite by nitrate reductase. The reaction is followed by a colorimetric detection of nitrite as an azo dye product of the Griess reaction (28) .
6.c.Determination of prostaglandin E 2 level in gastric mucosa:
Gastric mucosal prostaglandin E 2 (PGE 2 ) was determined by enzymelinked immunosorbent assay (ELISA) using PGE 2 assay kit (R&D Systems,USA). The assay is based on the competitive binding technique in which PGE 2 present in a sample competes with a fixed amount of horseradish peroxidase (HRP)-labeled PGE 2 for sites on a mouse monoclonal antibody (29) .
Statistical Analysis:
Results were expressed as mean ± S.E.M. The mean was that of 8 observations. Data sets were examined by one-or two-way analysis of variance, and individual group means were then compared with students unpaired t-test. The statistical significance between the two means was considered significant at p value ≤ 0.05 using the student´s "t" test.
RESULTS
Effect of indomethacin on the development of gastric lesions and its alterations by pretreatment with atorvastatin:
Indomethacin induced marked ulcerative lesions achieving an ulcer index of 32.25±1.13. Pretreatment with atorvastatin significantly attenuated the development of gastric lesions induced by indomethacin and decreased the ulcer index to 20.25±1.54. (Figure 1 ). 
5-Effect of indomethacin on the volume and total acid output of gastric secretion and its alteration by pretreatment with atorvastatin:
In control rats, volume of gastric secretion was 2.25±0.16 ml/3hrs. There was no significant change in the volume of gastric secretion in Ator+INDO (0.83±0.05 ml/3hrs) as compared to 1.06±0.1 ml/3hrs in INDO group (figure 5). A significant decrease in total acid output was observed in Ator+INDO (93±1.4 mEq/3hrs) as compared to INDO (139±1.8 mEq/3hrs) figure (6). 
Effect of indomethacin on gastric juice proteolytic activity and its alteration by pretreatment with atorvastatin:
Indomethacin produced a significant increase in the pepsin level compared to the control rats 6.9±0.42 mg/ml for the control rats versus 13.6±0.5 mg/ml INDO. Administration of atorvastatin did not produce any significant change in the gastric juice pepsin activity when compared to indomethacin group (12.5±0.49 mg/ml). 
DISCUSSION
Since many years, NSAIDs are widely prescribed and used for their anti-inflammatory, antipyretic, and analgesic effects. The major limitation of their clinical application are their serious side effects such as induction of acute hemorrhagic erosions, potentiation of gastric ulcerogenic response to various stimuli and impairment of healing of pre-existing ulcer (13) . . Pretreatment with atorvastatin in case of indomethacin induced ulcers showed a significant reduction in mucosal lipid peroxides . This suggested that free radical scavenging property of atorvastatin may be part of its mechanism against indomethacin-induced gastric ulcers, especially as free radical production has been proposed by more than one author to be a key detrimental factor in indomethacin-induced ulcers (12) . NO is a putative signaling molecule recognized for its ability to enhance gastric mucus/alkaline secretion, inhibiting gastric acid secretion and prevent neutrophil activation and adherence to vascular endothelium thus affording gastro protection. Earlier studies revealed that endogenous NO released from vascular endothelium, sensory nerves or gastric epithelium cooperates with endogenous prostaglandins in the maintenance of gastric mucosa integrity and microcirculation (5) . A previous report has shown that NO generated from transdermal nitroglycerin protected against indomethacin-induced gastric ulceration through maintenance of mucosal blood flow and reduction of leukocyte endothelial cell rolling and adherence (40) . In the present study, The increase in mucosal generation of PGE 2 observed after treatment with atorvastatin is probably mediated, at least in part, by NO. Thus, the gastroprotection afforded by atorvastatin could be attributed to the interaction of NOS and COX and their products, NO and PGE 2 in gastric mucosa. A mutual interaction was shown to exist between NOS and COX enzymes and has been confirmed by many investigators (43, 44) . NO was reported to increase PGE 2 biosynthesis in vivo through a cGMPindependent mechanism and it is possible to assume that NO might regulate the release and/or the biosynthesis of PGE 2 in the stomach after damage (45) . Gastric mucus plays a critical role in the production of gastric barriers (46) . In the present study, the gastric juice mucin concentration was reduced in indomethacin-treated rats. Pretreatment with atorvastatin significantly increased gastric juice mucin concentration compared to nontreated indomethacin group. It has been shown that NO stimulates gastric mucus synthesis and secretion (47) and impairment of gastric mucus secretion occurs through a decrease in gastric mucosal NOS activity in indomethacin-treated rats (48) . Additionally, earlier studies showed that prostaglandins exert a gastroprotective action against gastric mucosal lesions through maintenance of gastric mucus synthesis and secretion (49) . Therefore, it could be stated that the increase in gastric juice mucin concentration afforded by atorvastatin depends on the increase of NO and PGE 2 levels, a finding which is supported by the data of the present study.
The increase in gastric acidity is considered an important contributing factor in the pathogenesis of gastric ulcers. In the present study gastric acidity was significantly increased in indomethacin-treated rats. 
